No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
UBS Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend
This ResMed Insider Reduced Their Stake By 72%
ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum
Why ResMed (RMD) Is a Top Growth Stock for the Long-Term
ResMed: The Acquisition Is Not Material to Resmed's Fincl Results >RMD